Vontobel Holding
IBRX icon

Vontobel Holding’s ImmunityBio IBRX Stock Holding History

Vontobel Holding’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Buy
25,343
+10,661
+73% +$73K ﹤0.01% 1117
2025
Q4 		$29.1K Sell
14,682
-11,109
-43% -$25.2K ﹤0.01% 1422
2025
Q3 		$63.4K Buy
25,791
+15,791
+158% +$40.7K ﹤0.01% 1316
2025
Q2 		$26.4K Sell
10,000
-6,000
-38% -$16.1K ﹤0.01% 1253
2025
Q1 		$48.2K Sell
16,000
-8,000
-33% -$24.2K ﹤0.01% 1063
2024
Q4 		$61.4K Hold
24,000
– – ﹤0.01% 1062
2024
Q3 		$89.3K Hold
24,000
– – ﹤0.01% 1037
2024
Q2 		$152K Buy
+24,000
New +$158K ﹤0.01% 1006

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vontobel Holding's IBRX Position: Q1 2026 in Review

Vontobel Holding increased its ImmunityBio (IBRX) stake by 73% in Q1 2026, buying an estimated $73K and bringing the position to 25,343 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Vontobel Holding first reported a position in IBRX in Q2 2024 and has held it in 8 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Vontobel Holding held 25,343 shares of ImmunityBio worth $194K as of Q1 2026.
  • Vontobel Holding bought 10,661 ImmunityBio shares in Q1 2026, an estimated $73K.
  • ImmunityBio made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1117 holding.
  • Vontobel Holding first reported a position in ImmunityBio in Q2 2024 and has held it in 8 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.